|
MPHOSPH6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.30009999830006E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.86739999966201E-07 |
| Normal-vs-Stage2 |
2.677100E-03 |
| Normal-vs-Stage3 |
2.876900E-03 |
| Normal-vs-Stage4 |
1.663570E-01 |
| Stage1-vs-Stage2 |
9.302000E-01 |
| Stage1-vs-Stage3 |
8.769000E-01 |
| Stage1-vs-Stage4 |
4.760200E-01 |
| Stage2-vs-Stage3 |
9.671800E-01 |
| Stage2-vs-Stage4 |
4.773200E-01 |
| Stage3-vs-Stage4 |
5.010000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.09820000157879E-08 |
| Normal-vs-AfricanAmerican |
3.180000E-04 |
| Normal-vs-Asian |
2.26409999999344E-05 |
| Caucasian-vs-AfricanAmerican |
3.997000E-01 |
| Caucasian-vs-Asian |
1.776760E-01 |
| AfricanAmerican-vs-Asian |
9.578500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.76469999969254E-07 |
| Normal-vs-Female |
7.72699999540549E-08 |
| Male-vs-Female |
2.879700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.209100E-04 |
| Normal-vs-Extreme_Weight |
1.61929999997756E-06 |
| Normal-vs-Obese |
3.758500E-04 |
| Normal-vs-Extreme_Obese |
6.048000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.677200E-01 |
| Normal_Weight-vs-Obese |
9.781800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.243800E-01 |
| Extreme_Weight-vs-Obese |
6.876600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.160040E-01 |
| Obese-vs-Extreme_Obese |
2.638800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.88331999999569E-05 |
| Normal-vs-Age(41-60Yrs) |
8.57760000028129E-07 |
| Normal-vs-Age(61-80Yrs) |
2.23549999955885E-07 |
| Normal-vs-Age(81-100Yrs) |
2.617800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.591800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.886400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.165030E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.852000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.575800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.346800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.76950000208009E-08 |
| Normal-VS-Type2 PRCC |
6.302100E-03 |
| Normal-VS-KIRP CIMP |
3.562400E-02 |
| Normal-VS-Unclassified PRCC |
1.809280E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.840100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.330400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.096400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.093600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.091980E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.804800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.639760E-03 |
| Normal-vs-N1 |
1.319940E-03 |
| Normal-vs-N2 |
8.070100E-02 |
| N0-vs-N1 |
2.891200E-01 |
| N0-vs-N2 |
4.337500E-02 |
| N1-vs-N2 |
2.136500E-02 |
|
|
